Evidence map›Paper›PMID 31409642›Full record

ArticleThe Journal of biological chemistry2019

Fully hydrophobic HIV gp41 adopts a hemifusion-like conformation in phospholipid bilayers.

Myungwoon Lee, Chloe A Morgan, Mei Hong

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Myungwoon LeeDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Chloe A MorganDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Mei HongDepartment of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 meihong@mit.edu.ORCID 0000-0001-5255-5858

Funding

Structures and lipid interactions of curvature-inducing membrane peptides by NMRR01GM066976 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI HONG, MEI · 2003 to 2021
$4.8M
NIGMS NIH HHS R01 GM066976
6 · The paper itself

Abstract

The HIV envelope glycoprotein mediates virus entry into target cells by fusing the virus lipid envelope with the cell membrane. This process requires large-scale conformational changes of the fusion protein gp41. Current understanding of the mechanisms with which gp41 induces membrane merger is limited by the fact that the hydrophobic N-terminal fusion peptide (FP) and C-terminal transmembrane domain (TMD) of the protein are challenging to characterize structurally in the lipid bilayer. Here we have expressed a gp41 construct that contains both termini, including the FP, the fusion peptide-proximal region (FPPR), the membrane-proximal external region (MPER), and the TMD. These hydrophobic domains are linked together by a shortened water-soluble ectodomain. We reconstituted this "short NC" gp41 into a virus-mimetic lipid membrane and conducted solid-state NMR experiments to probe the membrane-bound conformation and topology of the protein.

Indexed as

Cell MembraneGene Expression Regulation, ViralHIV-1HIV Envelope Protein gp41HIV InfectionsHumansHydrophobic and Hydrophilic InteractionsLipid BilayersModels, MolecularPhospholipidsProtein ConformationProtein Conformation, alpha-HelicalProtein Conformation, beta-StrandProtein DomainsVirus InternalizationWaterHIV Envelope Protein gp41Lipid BilayersPhospholipidsWaterfusion proteinmembrane fusionmembrane structuresolid state NMRstructural biologyvirus entry

Identifiers

PMID31409642
PMCPMC6779440

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.